U.S. markets open in 9 hours 23 minutes
  • S&P Futures

    3,653.00
    -7.50 (-0.20%)
     
  • Dow Futures

    29,687.00
    -117.00 (-0.39%)
     
  • Nasdaq Futures

    12,439.25
    -13.00 (-0.10%)
     
  • Russell 2000 Futures

    1,832.70
    -2.80 (-0.15%)
     
  • Crude Oil

    44.15
    -0.40 (-0.90%)
     
  • Gold

    1,812.50
    -6.40 (-0.35%)
     
  • Silver

    23.82
    -0.27 (-1.12%)
     
  • EUR/USD

    1.2077
    -0.0001 (-0.01%)
     
  • 10-Yr Bond

    0.9340
    +0.0900 (+10.66%)
     
  • Vix

    20.77
    +0.20 (+0.97%)
     
  • GBP/USD

    1.3417
    -0.0006 (-0.05%)
     
  • USD/JPY

    104.3900
    +0.0740 (+0.07%)
     
  • BTC-USD

    18,500.02
    -196.16 (-1.05%)
     
  • CMC Crypto 200

    363.29
    -16.57 (-4.36%)
     
  • FTSE 100

    6,384.73
    +118.54 (+1.89%)
     
  • Nikkei 225

    26,830.61
    +43.07 (+0.16%)
     

The Zacks Analyst Blog Highlights: Zoom Video, salesforce, Thermo Fisher, FedEx and Square

Zacks Equity Research
·6 min read

For Immediate Release

Chicago, IL – October 7, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Zoom Video Communications Inc. ZM, salesforce.com inc. CRM, Thermo Fisher Scientific Inc. TMO, FedEx Corp. FDX and Square Inc. SQ.

Here are highlights from Tuesday’s Analyst Blog:

U.S. Stock Market Outshines Global Bourses Amid Pandemic

Wall Street's five-month-long rally suffered a severe setback in September owing to extreme volatility. U.S. markets are likely to continue fluctuating in October too for several economic and political reasons, which already made several market participants all the more jittery.

However, a closer look into the global equity investment arena clearly reveals that the U.S. stock markets are the best-performing investment landscape in the coronavirus-stricken 2020.

Globally U.S. Stock Markets Are the Best

The U.S. stock markets are the best destination for investors. Between the post-recession era and the outbreak of the novel coronavirus, overall returns of U.S. stocks were nearly four times higher than the rest of the world. After successfully recovering from the Great Recession, Wall Street also recovered overwhelmingly from the trade-related assault of 2018.

Wall Street is poised to keep the flag high amid coronavirus-led devastations too. In the past six months, major European indexes such as DAX of Germany, FTSE 100 of the U.K., CAC 40 of France and the pan-European STOXX 600 gained 27.3%, 6.5%, 12.1% and 14.1%, respectively.

Major Asia-Pacific indexes like NIKKEI 225 of Japan, Shanghai Composite of China, Hang Seng of Hong Kong, KOSPI of South Korea and ASX of Australia gained 23.7%, 14.1%, 1%, 29.6% and 13.5%, respectively, in the same time frame.

In the past six months, major U.S. stock indexes like the Dow, the S&P 500 and the Nasdaq Composite have rallied 24.1%, 28% and 43.2%, respectively. Overall, Wall Street's performance is much better than the overall European and Asia-Pacific regions.

Excluding last month’s severe volatility — which originated from U.S. specific factors (like the resurgence of coronavirus, the absence of new fiscal stimulus and the upcoming presidential election), performance of the U.S. stock markets could have been much better.

Solid Fundamentals of the U.S. Economy

The gigantic size of the U.S. economy has given it a clear upper hand over European and emerging markets. Furthermore, geopolitical conflicts are not going to harm the United States as much as the rest of the world. Technological innovation has always been a pillar of U.S. economic strength.

The U.S. government and the Fed have already injected around $7 trillion of stimulus to sustain the economy during the pandemic. A Congressional settlement for the second round of the coronavirus aid package will immediately boost investors' confidence in risky assets like equities. Notably, the latest Conference Board data revealed that Americans expressed their highest level of confidence in the economy in September since March.

Moreover, the Fed reiterated that the benchmark interest rate will stay zero or near zero at least up to 2023. The central bank will also pursue its existing $120 billion monthly purchase of assets in the form of U.S. Treasury and mortgage bonds until the economy returns to normalcy or the pre-pandemic level. The Fed's ultra-dovish monetary stance is a long-term positive for the stock market.

A low-interest rate will reduce the cost of capital for businesses and consumers have a lesser propensity to save due to a low deposit rate. Therefore, higher spending by businesses and consumers is likely to boost the overall economy and raise stock prices. Moreover, a low discount rate will increase the net present value of the investment in equities.

How to Pick the Right Stocks

At this stage, it will be prudent to invest in large-cap (market capital > $50 billion) stocks with a favorable Zacks Rank. These companies have well-established businesses, solid liquidity and brand names. Also, we have select stocks with strong short-term and long-term (3-5 year) growth potential that have witnessed robust earnings estimate revisions within the last 60 days. These stocks have rallied more than 50% to more than 300% in the past six months.

Major stocks that fall in this category include Zoom Video Communications Inc., salesforce.com inc., Thermo Fisher Scientific Inc., FedEx Corp. and Square Inc. Each of our picks carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Join us on Facbook: https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Click to get this free report FedEx Corporation (FDX) : Free Stock Analysis Report salesforce.com, inc. (CRM) : Free Stock Analysis Report Thermo Fisher Scientific Inc. (TMO) : Free Stock Analysis Report Square, Inc. (SQ) : Free Stock Analysis Report Zoom Video Communications, Inc. (ZM) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research